Genfit SA

GENFIT appoints Jean-François Tiné to the Board of Directors

04 Mar 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Revenues and Cash Position as of December 31, 2020

26 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: new market research data highlight potential of elafibranor in PBC

22 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: 2021 Financial Calendar

10 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology

09 Feb 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Two Key Appointments to the Executive Committee

28 Jan 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT: Technical Corrections to the Results of the January 25, 2021 Bondholders Meeting with No Impact on Resolutions’ Approval

27 Jan 2021 15:30:00 By Nasdaq GlobeNewswire

GENFIT: Sweeping approval of OCEANEs buyback and amendments of terms

25 Jan 2021 13:30:03 By Nasdaq GlobeNewswire

GENFIT announces that its Extraordinary General Meeting on second notice will be held January 25, 2021 and informs the OCEANEs holders of certain procedures for the Bondholders’ Meeting of January 25, 2021

13 Jan 2021 16:10:00 By Nasdaq GlobeNewswire

January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening

12 Jan 2021 14:15:00 By Nasdaq GlobeNewswire

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

11 Jan 2021 16:10:00 By Nasdaq GlobeNewswire

GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary General Meeting of January 13, 2021

08 Jan 2021 12:30:00 By Nasdaq GlobeNewswire

GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event

06 Jan 2021 16:10:00 By Nasdaq GlobeNewswire